GTHP

$0.15+7.14%visit website

GUIDED THERAPEUTICS INC

Market Cap

$14M

Live price × SEC shares (Aug 7, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.72

60mo monthly vs SPY

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

22.3

TTM to Jun 2026 · revenue

P/B

N/M

TTM to Jun 2026 · negative equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	60	590	0	0	650
Cost of revenue	25	132	0	0	157
Gross profit	35	458	0	0	493
Research & development	136	127	45	34	342
Total operating expenses	520	1,168	302	478	2,468
Operating income	(485)	(710)	(302)	(478)	(1,975)
Interest expense	129	184	151	136	600
Pretax income	(742)	(1,218)	(500)	(605)	(3,065)
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(742)	(1,218)	(500)	(605)	(3,065)
EPS (basic) ($)	(0.01)		(0.01)	(0.01)	(0.04)
EPS (diluted) ($)	(0.01)		(0.01)	(0.01)	(0.04)
Weighted avg. shares (basic)	81,689		88,836	96,536
Weighted avg. shares (diluted)	81,689		88,836	96,536

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 13, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 59 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Mar 10, 2026 accepted 7:01 PM ET	1.01Material agreement3.02Unregistered equity sale8.01Other events	Document SEC ↗
Dec 23, 2024 accepted 6:21 PM ET	1.01Material agreement	Document SEC ↗